A detailed history of Gold Investment Management Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gold Investment Management Ltd. holds 12,772 shares of BMY stock, worth $751,887. This represents 0.27% of its overall portfolio holdings.

Number of Shares
12,772
Previous 12,751 0.16%
Holding current value
$751,887
Previous $530 Million 23.58%
% of portfolio
0.27%
Previous 0.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$39.66 - $51.75 $832 - $1,086
21 Added 0.16%
12,772 $654 Million
Q2 2024

Jul 25, 2024

SELL
$40.25 - $52.99 $43,872 - $57,759
-1,090 Reduced 7.88%
12,751 $530 Million
Q1 2024

May 03, 2024

BUY
$47.98 - $54.4 $12,570 - $14,252
262 Added 1.93%
13,841 $751 Million
Q4 2023

Feb 12, 2024

BUY
$48.48 - $57.85 $658,309 - $785,545
13,579 New
13,579 $697 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gold Investment Management Ltd. Portfolio

Follow Gold Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gold Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gold Investment Management Ltd. with notifications on news.